Capek John M

Avg. Two Year Performance

No purchase track record
(14%) Avg. Sale Return
(7%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return< 1%(< 1%)(5%)(8%)(14%)
Sale Success Rate3 of 83 of 80 of 81 of 81 of 8

Abbott Laboratories

Drugs » Drug Manufacturers - Major

Executive Vice President:

Holdings: 339.44K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--